Item - 2022.HL36.5

The Board of Health:

1.  Directed the Medical Officer of Health and the Associate Director, Toronto Drug Strategy Secretariat to:

a.  create a specific Two-Spirit, Lesbian, Gay, Bisexual, Transgender and Queer Drug Strategy as a component of the Toronto Drug Strategy;

b.  incorporate the Two-Spirit, Lesbian, Gay, Bisexual, Transgender and Queer Advisory Committee's feedback into the creation of the strategy and consult with Sherbourne Health, AIDS service organizations, The 519 and other Two-Spirit, Lesbian, Gay, Bisexual, Transgender and Queer health service providers;

c.  create educational materials and campaigns with the objective of promoting sexual health as it relates to the strategy and ending the stigma and discrimination that members of the Two-Spirit, Lesbian, Gay, Bisexual, Transgender and Queer community face; and

d.  request the Provincial and Federal Governments to invest in the development and implementation of the strategy.

2.  Directed the Associate Director, Toronto Drug Strategy Secretariat, to present an update on theimplementation of the Toronto Drug Strategy to the Two-Spirit, Lesbian, Gay, Bisexual, Transgender and Queer Advisory Committee in 2022.

At its meeting on February 2 and 3, 2022, City Council considered Item EX29.7 and made recommendations to the Board of Health.